Skin TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell TransplantationGraft RejectionLiver TransplantationGraft SurvivalBone Marrow TransplantationKidney TransplantationTransplantation ConditioningStem Cell TransplantationHeart TransplantationLung TransplantationMultiple MyelomaMice, Inbred BALB CCell TransplantationMice, Inbred C57BLPeripheral Blood Stem Cell TransplantationTreatment OutcomeMelphalanOrgan TransplantationHematopoietic Stem Cell MobilizationGraft vs Host DiseaseCombined Modality TherapySkinPancreas TransplantationIslets of Langerhans TransplantationTissue DonorsTransplantation ImmunologyTransplantationRecurrenceLymphoma, Non-HodgkinImmunosuppressive AgentsSalvage TherapyAntigens, CD34Whole-Body IrradiationTransplantation ChimeraBone Marrow PurgingRetrospective StudiesCarmustineCyclophosphamideRemission InductionHematopoietic Stem CellsAntineoplastic Combined Chemotherapy ProtocolsGranulocyte Colony-Stimulating FactorTime FactorsSurvival AnalysisLeukapheresisHematologic NeoplasmsTransplantation, IsogeneicBusulfanDisease-Free SurvivalSurvival RateLiving DonorsTransplantation, HeterotopicCord Blood Stem Cell TransplantationFollow-Up StudiesHeart-Lung TransplantationEtoposideHodgkin DiseaseTransplantation ToleranceTissue and Organ ProcurementMyeloablative AgonistsCytarabineBlood Transfusion, AutologousImmunosuppressionGraft vs Tumor EffectHistocompatibility TestingLiver FailureFetal Tissue TransplantationBone MarrowPostoperative ComplicationsPrognosisMesenchymal Stem Cell TransplantationLeukemiaTransplantation, HeterologousCells, CulturedThalidomideWaiting ListsSkin DiseasesTissue TransplantationFeasibility StudiesSkin NeoplasmsHematopoiesisHistocompatibilityKanamycin KinaseCorneal TransplantationVincristineBone Marrow CellsBlood Component RemovalLymphomaLeukemia, Myeloid, AcuteStem CellsSkin AgingTacrolimusNeoplasm, ResidualCell SeparationCyclosporinePrednisoneMyelodysplastic Syndromes